Background {#Sec1}
==========

Pompe disease (glycogen storage disease type II, GSD II) is a progressive metabolic myopathy caused by a deficiency of the lysosomal acid alpha-glucosidase. This enzyme deficiency leads to an accumulation of glycogen, mainly in the muscles, resulting in their progressive destruction \[[@CR1], [@CR2]\]. The spectrum of clinical phenotypes includes an infantile form (classic form) and a late-onset form (with both juvenile and adult presentations). In the juvenile form (late-onset) the first symptoms, such as progressive proximal and axial muscle weakness, appear between 2--5 years of age. The adult form (late-onset) has a slower progression, with the first symptoms appearing in adulthood. Late-onset clinical features include progressive muscle weakness, with particularly damaging effects in respiratory muscles, necessitating ventilator-assisted breathing in advanced stages \[[@CR3]\]. With disease progression, the effects of muscle cell damage and destruction display clearer clinical manifestations, with abnormalities developing in the voice apparatus.

Patients with advanced late-onset Pompe disease experience speech disorders in all forms of the disease \[[@CR3]--[@CR6]\]. In addition Hobson-Webb et al. \[[@CR5]\] described the presence of articulation disorders and dysarthria in late-onset Pompe disease patients. Jones et al. revealed lingual weakness to be present in 80 % of subjects with late-onset Pompe disease \[[@CR6]\]. Papers published to date have not employed electroglottographic, acoustic nor nasalance testing methods in the clinical assessment of late-onset Pompe disease. However, these investigative methods have been successfully used to study voice disorders \[[@CR7]--[@CR9]\] and are widely available, inexpensive and non-invasive. The authors wished to study whether these methods could be applied to assess voice quality and thereby measure the effectiveness of ERT in late-onset Pompe disease on the functioning of the voice apparatus. These methods are automated and possess the advantages of objectivity, repeatability and comparability. According to Jones et al. \[[@CR6]\] it is important to find methods that increase suspicion of late-onset Pompe disease.

Methods and patients {#Sec2}
====================

The study and its consent procedure were approved by the Bioethics Committee (133/KBE/2014) of the Children's Memorial Health Institute in Warsaw. All study subjects gave informed, written consent prior to their participation; consent on behalf of all children taking part was given in writing by their parents or guardians. The study examined 19 patients with late-onset Pompe disease, from 14 families, ranging in age from 7 to 54. The mean age of patients at the time the study was performed was 28.2 years, with a median of 39. 9 patients had the juvenile form (group 1) and 10 had the adult form (group 2) of the disease. All patients were on ERT at the moment of investigation. The therapy lasted from 3 to 8 years. Patients' clinical data, mutation and length of ERT are shown in Table [1](#Tab1){ref-type="table"}. Table 1Patient demographicsIDGenderCurrent age yearsAge of first symptoms yearsAge of diagnosis yearsYears on ERTMutationForm1F11.8no symptoms, family screening27IVS1-13T\>G/c.2662G\>TJuv2M15.5no symptoms, family screening67IVS1-13T\>G/c.2662G\>TJuv3F17.922.57IVS1-13T\>G/c.307T\>GJuv4M25.66157IVS1-13T\>G/c.2662G\>TJuv5F8.30.526L291F, 871C\>T/R600C, 1798C\>TJuv6F7.511.56.52495delCA (ex18)/2495delCA (ex18)Juv7M8.5no symptoms, family screening0.66G377S c.2495_2496 delCAJuv8F14.8348C1129G\>A/c.2495_2496 delCAJuv9M17.83.547IVS1-13T\>G/c.925G\>AJuv10F406317c.364A\>G/c.1796C\>TAdult11F317257IVS1-13T\>/C103GAdult12M37.527297c.364A\>G/c.1796C\>TAdult13F3925343IVS1-13T\>G/C103G, 307T\>GAdult14M46.535407IVS1-13T\>G/c.307T\>GAdult15F53.830465.5IVS1-13T\>G/525delTAdult16M34.815257IVS1-13T\>G/c.307T\>GAdult17M53.833488IVS1-13T\>G/C103G, 307T\>GAdult18M37.828325IVS1-13T\>G/c.307T\>GAdult19F33.826305IVS1-13T\>G/c.307T\>GAdultTable [1](#Tab1){ref-type="table"}. Juv - juvenile

Patients were invited to participate in a phoniatric evaluation of their voice apparatus, alongside electroglottographic, acoustic and nasalance measurement methods of evaluation.

Phoniatric evaluation of the voice apparatus {#Sec3}
--------------------------------------------

A phoniatric examination was performed on 17 out of the 19 patients, including an assessment of ears, nose, oral cavity, nasopharynx, middle and lower oropharynx and larynx. The study was supplemented by voice quality assessment based on perceptual evaluation of voice quality on the GRBAS scale \[[@CR10], [@CR11]\]. Phoniatric examination of the condition of the vocal tract was carried out with an endoscopic set (video-otoscope 0.6 mm, flexible video-fiberscope 2.5 mm, 90-degree Hopkins video-laryngoscope) and a Carl Zeiss ear microscope. The breathing pattern of each patient was evaluated by observing chest and neck movements, how the voice was created, phonatory and breathing coordination, and phonation time. Nasalance assessment was conducted using Czermak's mirror test (mirror-fogging test) of nasal air escape.

Acoustic method of voice quality analysis {#Sec4}
-----------------------------------------

Nineteen patients with late-onset Pompe disease participated in acoustic and electroglottographic recordings. Equipment from Glottal Enterprises, a Nasalance Separator Handle and an EG2-PCX2 electroglottograph with microphone were used in the study. The noise signal was reduced by 40 dB in the acoustic signal as well as in the electroglottographic signal.

Electroglottography {#Sec5}
-------------------

An analysis of the electroglottographic signal has been shown to correlate best with various types of voice quality. In comparison to modal phonations, it is possible to differentiate between a breathy voice, a creaky voice and a tense voice. EGG was used to detect vocal fold vibration pattern \[[@CR7], [@CR12], [@CR13]\].

To carry out the analysis, the parameters CQ H (Closing Quotient) and SQ (Speed Quotient) were calculated. CQ H measures the duration of the closing phase of the glottal cycle and is a hybrid calculation, using the EGG contacting peak for detecting the glottal contact event, and an EGG-based 3/7 threshold for detecting the glottal opening event \[[@CR14]--[@CR16]\]. SQ (Speed Quotient) is the ratio between increased contact during the closing phase duration and opening phase durations of the glottal cycle. It is an expression of the symmetry of glottis air exchange \[[@CR17]\].

For EGG recordings, patients phonated the vowel /a/ three times for a sustained period with natural volume. These recordings were used to assess vocal fold vibration and voice quality. MATLAB (COVAREP toolkit) was used for further analysis \[[@CR18]\].

Acoustic analysis {#Sec6}
-----------------

Four parameters (Peak Slope, NAQ, HRF & CPPv) \[[@CR19], [@CR20], [@CR22], [@CR23]\] were used to assess voice quality in patients with late-onset Pompe disease. Peak Slope has demonstrated the ability to differentiate between breathy modal and tense voice. The main advantage of the Peak Slope algorithm is that it functions as a standalone program. Normalized Amplitude Quotient (NAQ) has been used in prior studies to assess tense voice.

Both parameters can be applied, even in recordings with background noise. The experiments demonstrated, among other things, that applying the NAQ parameter to calculations on real speech signals allows for differentiation between normal, breathy and pressed phonations \[[@CR19]--[@CR21]\]. Employing the Harmonic Richness Factor (HRF) parameter permits the detection of dysphonia \[[@CR22]\] and the Cepstral Peak Prominence parameter allows detection of early dysphonia. The efficacy of the CPPv method has been validated in prior work by Hillenbrand et al., and Maryn et al., \[[@CR23], [@CR24]\]. The occurrence of subharmonics in the EGG signal was examined by Praat \[[@CR25], [@CR26]\].

For the purposes of the acoustic analysis, the microphone signal obtained in the EGG recordings was used.

Nasalance measurements {#Sec7}
----------------------

The Nasalance Separator Handle (Glottal Enterprises), a computer-assisted instrument similar to a nasometer \[[@CR27]\], was used in this study for tracking variations in nasalance (the acoustic correlate of perceived nasality), which is the ratio of nasal over nasal plus oral acoustic energy during speech. The value of this coefficient depends strongly on the nasal surface of the velum, which in the case of nasal speech is relatively large \[[@CR28]\].

Hajja \[[@CR29]\] demonstrated that acoustic examination of nasality changes is efficient for tracking the progress of nasal speech rehabilitation.

Nasalance recording of the following sounds was carried out: sequences of the Polish vowels /y/ /e/ /a/ /o/ /u/ /i/; voiced plosives separated by vowels (sequence type: V-VP-V-VP\...); and nasal consonants separated by vowels and the sustained vowel /i/. The entire recording was used to assess nasality.

Results {#Sec8}
=======

A summary of the test results is presented in Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"} and Fig [1](#Fig1){ref-type="fig"}. Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} show the results of the phoniatric examination, including the assessments of the oral cavity, ears, nose and larynx. Table [4](#Tab4){ref-type="table"} shows the results of the acoustic and electroglottographic analyses. Figure [1](#Fig1){ref-type="fig"} shows the result of hypernasal speech. Fig. 1Nasalization analysis of two sustained vowel sounds /i/ articulated by patients with late-onset Pompe disease (group 1). Two time signals (top), measurement of the nasalization coefficient (central) and time level variations in dB (bottom) of nose (continuous line) and mouth (broken line) signals. In healthy children's voices, this coefficient does not exceed 20 %. This is typical for hypernasal speechTable 2Laryngological examination results in patients with late-onset Pompe diseaseIDCzermak scoreOral cavityNoseEars1NDNDSNN2NDNNN32SP atonic, LMPhNN4NDSP atonic, LMPhNN52Tonsillar hypertrophy, Short SP, Short SPOMS bil62SP atonic, short LMPhNN72Short atonic SP LMPh, atonic tongueConchal ON82Short atonic SP, LMPh, atonic tongueDSNN90NDSNEpitympanal retr.101Short atonic SP, LMPh Lack of pharyngeal reflexes, Geographic tongue, Malocclusion (open bite)NN110N - Normal palateNN120SP LMPhNN13NDNDNDND140Long slender, movable, SPDSNN151N - Normal palateNMin. retractions of the drums160N - Normal palateNN170N - Normal palate Hypertrofia Tonsillae,NOsteoma in the right external auditory meatus181Short SP, PPHI, LMPhDSNN191Short SP, PPHIConchal OEpitympanal retr.Table [2](#Tab2){ref-type="table"}. SP -- soft palate; LMPh -- limited mobility during phonation; DSN -- deviation of nasal septum; OMS -- otitis media secretoria; PPHI -- palatopharyngeal insufficiency; retr -- retractions; ND -- not doneTable 3Video-laryngoscopic examination results in patients with late-onset Pompe diseaseIDLarynx diagnosisAge of dysphonia/durationGRBASMPTVestibulum of larynxVocal foldsArytenoid area1NNo000006 s.NGI pp, VF thickened, thick mucusMin. C2NNo000008 s.NMin. VF thickenedN3GI Laryngeal tremorNo data0010010 s.NGI mp, VF tremor thick mucus on VFC, O4NNo data101004 s.NVFC, mucus on VFN5Hyperfunctional dysphoniaNo data0000110 s.Phonation of VsPNC6No dataNo dataNo dataNo dataNo dataNo dataNo data7GI4 H, silent soundless matte V0022012 s.NGI mpMin. C, O8GI13/0.1, silent soundless matte V1011012 s.NGI mpC, O, mucus retention9NNo0000020 s.NNN10GI Laryngitis posterior25/10 H1000015 s.NGIC, O Laryngitis posterior11NNo0000015 sNNN12GI30/8 morning H cough0000018 s.NGI mpMin. C13No dataNo dataNo dataNo dataNo dataNo dataNo data14GI37/10001108 s.Enlarged rVsF covers rVFGI Oblique orientation of glottis.N15GINo V fatigue0011011 s.NGI mp. VF CC, O16NNo001005 s.NVF thickened, tremorMin. C, O17GI38/40010022 s.NGI mpC, O18GINo V fatigue100005 s.NGI mpMin. C. As. r aryt. Moved forward19GINo data001004 s.NGI mpNTable [3](#Tab3){ref-type="table"}. GI - Glottal insufficiency; VF -- vocal folds; VsF -- vestibular folds; C -- congestion; O - oedema; mp - middle part of the glottis; Min. -- minimal; H -- hoarseness; V -- voice; r -- right; N -- normal, MPT --maximum phonation timeTable 4Coefficients for PS, NAQ, HRF, CPPv, CQ H and SQ values were obtained during prolonged phonation of /a/. In addition, the CQ H coefficient was calculated for its fragmentsIDPSNAQHRFCPPvCQ HCQ H 2 sec.CQ H 1sec.SQ1-0.210.1114.7211.900.450.380.360.282-0.400.1034.2011.360.310.270.260.853-0.220.0913.6011.810.450.430.420.304-0.390.0930.9710.950.360.340.340.605-0.060.0816.1011.570.200.180.171.606-0.120.1112.7011.360.340.340.310.387-0.020.1613.6011.250.300.290.280.288-0.160.1111.9011.540.370.320.300.389-0.500.1237.4910.310.230.230.231.2010-0.430.1917.5111.570.290.280.270.8411-0.290.0819.2012.490.460.450.430.1312-0.260.1317.1111.460.440.400.370.2913-0.330.1417120.430.390.380.4314-0.480.1521.8511.930.370.340.330.4515-0.100.1212.7011.400.390.360.35-16-0.430.1129.3011.520.240.220.21-17-0.440.1826.6711.760.320.300.281.0818-0.340.1030.6411.240.300.280.27-19-0.090.091311.510.350.340.33-

Phoniatric assessment results {#Sec9}
-----------------------------

In group 1, voice irregularities were observed in all the patients (tense voice type), characterized by excessive muscle tension of the shoulder girdle, neck and submandibular areas. Voice pitch was altered in all the patients in group 1.

Dysphonia was observed in 5 out of 8 patients in group 1. Only 2 patients independently noticed symptoms of hoarseness (indicating dysphonia). Angioedema caused minimal changes to the vocal folds in 3 patients, and an accumulation of mucus presented in 3 patients. Changes in the posterior commissure were observed in 5 patients. Swelling of different intensities was observed in 3 patients, while minor redness was seen in 5 patients. Features of hyperfunction, expressed by vestibular fold phonation, were observed in one patient.

Glottal phonatory insufficiency, being a lack of full vocal fold closure in phonation, was observed in 3 patients. Severe nasality was observed in 5 patients. This resulted from either the soft palate being short, limited palate mobility or both and was also confirmed by the Czermak test (Table [2](#Tab2){ref-type="table"}).

In group 2, phoniatric tests were carried out on 9 out of 10 patients (Table [3](#Tab3){ref-type="table"}). Dysphonia, caused by excessive muscle tension in the shoulder girdle, neck and submandibular areas, was observed in 7 out of 10 patients. Fluctuations in voice pitch and tense voice were observed in these patients.

Voice quality disorders were observed in 6 patients; 3 of them were able to report when their dysphonia first appeared.

Glottal insufficiency was observed in 7 patients using video-laryngoscopic examination, with the middle part of the glottis primarily affected (5 patients). Swelling of the posterior commissure was observed in 4 patients and varying degrees of redness were seen in 5. Asymmetry in laryngeal structures was found in 2 patients and fluctuations in voice pitch in one of them.

Soft nasality was observed in 3 patients. This resulted from either the soft palate being short, limited palate mobility or both and was also confirmed by the Czermak test. Proper functioning of the soft palate was observed in the 6 remaining patients.

Electroglottographic and acoustic analyses results {#Sec10}
--------------------------------------------------

In group 1, closing insufficiency of the vocal folds during the whole phonation was observed in 7 out of 9 patients, and in 8 out of 9 patients in a phonation fragment of at least 2 seconds (Table [4](#Tab4){ref-type="table"} CQ H parameter). Significantly reduced SQ values were observed in 6 patients (mean=0.58, median=0.38, with a range from 0.28 to 1.6).

Clinically proven hyperfunctional dysphonia was found in one patient, where an SQ value of 1.6 was measured. These values differ significantly from normal values when using similar methods \[[@CR30]\]. Irregularity in the function of the vocal folds was observed in 5 patients. Nonsynchronous movement of vocal folds was observed in 1 patient.

Symptoms of dysphonia were observed in 7 patients and tense voice was observed in 8 patients (Table [4](#Tab4){ref-type="table"} parameters PS, NAQ, HRF & CPPv).

In group 2, glottal insufficiency was detected in 7 patients during the entire phonation and in 9 patients during at least 1 second of the phonation of the vowel /a/. The SQ value was observed to be significantly reduced in 4 patients (mean=0.63, median=0.44, with a range from 0.13 to 0.84) \[[@CR30]\]. Irregularity in the function of the vocal folds was observed in 5 patients. Nonsynchronous movement of the vocal folds was observed in 3 patients.

Symptoms of dysphonia were observed in 7 patients, and tense voice was observed in the other 7 patients with the adult form of the disease (Table [4](#Tab4){ref-type="table"} parameters PS, NAQ, HRF, CPPv).

Nasalance measurement results {#Sec11}
-----------------------------

In group 1, significant nasality was observed in 5 patients, and open nasality was observed in 2 patients. Velopharyngeal closure insufficiency was detected in 7 patients, and limited palate mobility in 1 patient. Significant speech nasality occurred in the same patients in whom vocal fold insufficiency was found.

In group 2, soft nasality was observed in 5 patients and limited movement of the soft palate and velopharyngeal closure impairment was seen in the other 4 patients.

Discussion {#Sec12}
==========

Progressive muscle damage in late-onset Pompe disease leads to changes in the voice and speech. A number of speech studies have evidenced articulation disorders and dysarthria, as reported in Dubrovsky et al, Fuller et al, Hobson-Webb et al, and Jones et al. \[[@CR3]--[@CR6]\].

Early onset of symptoms with rapid progression is classified as the juvenile form of the disease and its outcome is more severe. Patients with symptoms appearing later are classified as having adult form \[[@CR1], [@CR2]\].

The study compared the usefulness and efficacy of voice quality assessment by clinical phoniatric examination with electroglottographic, acoustic and nasalance measurement methods. The results obtained by all the different methods showed a close degree of compliance. However, acoustic methods showed higher sensitivity, objectivity and reproducibility of results in the studied patients. The parameters obtained in both phoniatric and acoustic analyses of both groups of patients with late-onset Pompe disease indicated significantly more pronounced symptoms in juvenile forms in comparison with adult forms.

Electroglottographic and acoustic analyses evidenced vocal fold insufficiency in both groups, as a consequence of the weakening of the voice muscles. This was consistent with the laryngological assessment. The applied signal parameterization and parameter calculation of the source signal allowed for a more detailed analysis and observation of closure insufficiency in more patients than with video-laryngoscopic examination.

In group 1, EGG the CQ H parameter indicated closing insufficiency in 8 patients in a phonation fragment of at least 2 seconds, compared to 3 patients in the phoniatric assessment.

In group 2, EGG the CQ H parameter detected glottal insufficiency in 7 patients during the entire phonation and in 9 patients for at least 1 second, compared to 7 patients in the phoniatric assessment.

Data inconsistency was observed only in the case of a single patient. This was likely an effect of the time difference between the performance of the phoniatric examination and the electroglottographic recording. The laryngoscopic study was performed four years previously.

The EEG analysis confirmed the irregular ratio of increased contact during the closing and opening phases of the glottal cycle, indicating abnormalities in the function of the laryngeal muscles.

The acoustic analysis parameters \[[@CR19], [@CR21]\] in the juvenile as well as in the adult form of the disease provided further evidence of a voice quality shift towards tense voice as a result of respiratory muscle weakness. Voice pitch fluctuation and variation of voice within the same phonation, were also observed. Short-term measurements of electroglottographic signals confirm this observation (Table [4](#Tab4){ref-type="table"}).

In group 1, the Peak Slope parameter indicated breathy voice phonation in 6 patients and tense voice in 3 patients in the whole phonation. The NAQ parameter indicated tense voice in 8 patients. The CPPv parameter indicated dysphonia in 7 patients in the whole phonation. The HRF parameter indicated dysphonia in 6 patients. The phoniatric assessment found dysphonia in 5 patients.

In group 2, the Peak Slope parameter indicated breathy voice phonation in 2 patients and tense voice in 5 patients in the whole phonation. The NAQ parameter indicated tense voice in 7 patients. The CPPv parameter indicated dysphonia in 7 patients in the whole phonation. The HRF parameter indicated dysphonia in 5 patients. The phoniatric assessment found dysphonia in 7 patients. The Peak Slope parameter had not been used for voice analysis until this study \[[@CR19]\].

In group 1, a subharmonic vibratory pattern produced in the larynx, functioning with half of the fundamental frequency (F0), was observed in 1 patient, and with group 2 in 3 patients.

It is noteworthy that the specification of the Peak Slope and NAQ parameters gave the opportunity to create a system for self-assessment of voice quality by a patient in the form of an application on his smartphone.

Phoniatric examination showed a short soft palate. In the juvenile form of late-onset Pompe disease, the process of muscle tissue atrophy is faster than in the adult form of late-onset Pompe disease. Therefore, the dysfunction of the voice apparatus is clearly marked. In the adult form, symptoms are less severe, and correlate with the weakness of other muscle groups. The Czermak test showed consistency with the nasality analysis. However, an acoustic analysis allows for more accurate determination of the degree of nasality and velum malfunction.

For the late-onset form of Pompe disease, an acoustic analysis was not carried out. The obtained results permitted an assessment of the dynamics of disease progression and treatment effects. The applied methods offer greater accuracy and reproducibility in the analysis of vocal fold function and allow an assessment of the type of phonation. Electroglottographic analysis was the most sensitive of all the methods used.

Since devices for performing acoustic measurements are not expensive, it is possible to develop a system allowing the patient to control the quality of voice with two parameters, PS and NAQ. In carrying out acoustic recordings, special acoustic conditions are not required, as has been proven by Kane \[[@CR19]\].

The presented methods permit an evaluation of some voice features, as well as nasality and vocal fold functioning. Furthermore, the ability to perform both long and short-term analyses allows the tracking of discrete changes in the vocal folds, which is undetectable with video-laryngoscopy assessment.

Conclusions {#Sec13}
===========

Electroglottographic, acoustic and nasalance measurement methods all proved to be more sensitive, repeatable, comparable and versatile than phoniatric examination. These methods are suitable for assessing voice quality and allow an evaluation of voice impairment in patients with late-onset Pompe disease.

The PS (Peak Slope) and NAQ (Normalized Amplitude Quotient) parameters allow the evaluation and tracking of voice changes in the patient under normal acoustic conditions.

The relatively low cost of the study, the ease of data retention and the reliability of the three analysis methods are significant advantages that could be exploited to increase the efficiency of tracking the dynamics of late-onset Pompe disease progression.

This study explored the range of pathological changes in voice in patients with late-onset Pompe disease, and the varying degrees in severity of these changes.
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